Every infant has a 3-5% risk of being born with a birth defect. Congenital anomalies caused by exposure to maternal medications or other environmental agents are especially important because they are potentially preventable.
TERIS is used by health care providers to better understand the fetal risks associated with exposures to medications and other environmental agents during pregnancy. The information can be used to facilitate clinical decision making and patient counseling.
TERIS has posted new information on the use of azithromycin, remdesivir and hydroxychloroquine during pregnancy. A new agent summary on the vertical transmission of SARS-CoV-2 is now available.
TERIS is a non-profit subscription-based service that is used and respected by clinicians and researchers around the globe.